Thermo Fisher Scientific Inc (0R0H.L)

Name: Thermo Fisher Scientific Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Pharmaceuticals

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$12.2B

Net Income

$2.0B

Operating Margin

18.8%

Free Cash Flow

$6.3B

Debt / Assets

51.5%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Thermo Fisher Scientific Inc (0R0H.L).
Income Statement (Quarterly)	2025-12-31	2025-09-27	2025-06-28	2025-03-29
Revenue	12,215,000,000	11,122,000,000	10,855,000,000	10,364,000,000
Cost of Revenue	7,579,000,000	6,470,000,000	6,807,000,000	6,119,000,000
Gross Profit	4,636,000,000	4,652,000,000	4,048,000,000	4,245,000,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,977,000,000	2,365,000,000	1,779,000,000	2,063,000,000
Operating Expenses	2,334,000,000	2,712,000,000	2,131,000,000	2,405,000,000
Operating Income	2,302,000,000	1,943,000,000	1,917,000,000	1,840,000,000
Interest Expense	365,000,000	347,000,000	404,000,000	303,000,000
Income Before Tax	2,123,000,000	1,828,000,000	1,711,000,000	1,606,000,000
Income Tax Expense	153,000,000	207,000,000	92,000,000	95,000,000
Net Income	1,975,000,000	1,616,000,000	1,617,000,000	1,507,000,000
Per Share
EPS	5.22	4.28	4.28	3.99
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Thermo Fisher Scientific Inc (0R0H.L).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	44,556,000,000	42,879,000,000	42,857,000,000	44,915,000,000
Cost of Revenue	27,778,000,000	25,151,000,000	25,744,000,000	25,904,000,000
Gross Profit	16,778,000,000	17,728,000,000	17,113,000,000	19,011,000,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	7,272,000,000	8,676,000,000	8,445,000,000	9,015,000,000
Operating Expenses	8,669,000,000	10,066,000,000	10,254,000,000	10,486,000,000
Operating Income	8,109,000,000	7,662,000,000	6,859,000,000	8,525,000,000
Interest Expense	1,419,000,000	1,654,000,000	1,375,000,000	726,000,000
Income Before Tax	7,267,000,000	6,995,000,000	6,298,000,000	7,835,000,000
Income Tax Expense	547,000,000	657,000,000	284,000,000	703,000,000
Net Income	6,737,000,000	6,335,000,000	5,995,000,000	6,950,000,000
Per Share
EPS	17.77	16.58	15.53	17.73
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Thermo Fisher Scientific Inc (0R0H.L).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	9,852,000,000	4,009,000,000	8,077,000,000	8,536,000,000
Short Term Investments	253,000,000	1,561,000,000	-1,967,000,000	0
Net Receivables	8,900,000,000	9,626,000,000	9,664,000,000	9,427,000,000
Inventory	5,425,000,000	4,978,000,000	5,088,000,000	5,634,000,000
Total Current Assets	28,707,000,000	22,137,000,000	24,589,000,000	25,229,000,000
Property Plant Equipment	10,565,000,000	10,795,000,000	9,448,000,000	10,873,000,000
Goodwill and Intangibles	65,200,000,000	61,386,000,000	60,690,000,000	58,674,000,000
Total Assets	110,343,000,000	97,321,000,000	98,726,000,000	97,154,000,000
Liabilities
Account Payables	0	3,079,000,000	2,872,000,000	3,381,000,000
Short Term Debt	3,533,000,000	2,475,000,000	3,604,000,000	5,851,000,000
Total Current Liabilities	15,189,000,000	13,332,000,000	14,012,000,000	17,010,000,000
Long Term Debt	35,852,000,000	30,300,000,000	31,308,000,000	28,909,000,000
Total Liabilities	56,807,000,000	47,650,000,000	51,884,000,000	53,006,000,000
Shareholders Equity
Retained Earnings	0	53,102,000,000	47,364,000,000	41,910,000,000
Total Shareholders Equity	53,415,000,000	49,584,000,000	46,735,000,000	43,978,000,000

Balance sheet annual history for Thermo Fisher Scientific Inc (0R0H.L).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	9,852,000,000	4,009,000,000	8,077,000,000	8,536,000,000
Short Term Investments	253,000,000	1,561,000,000	-1,967,000,000	0
Net Receivables	8,900,000,000	9,626,000,000	9,664,000,000	9,427,000,000
Inventory	5,425,000,000	4,978,000,000	5,088,000,000	5,634,000,000
Total Current Assets	28,707,000,000	22,137,000,000	24,589,000,000	25,229,000,000
Property Plant Equipment	10,565,000,000	10,795,000,000	9,448,000,000	10,873,000,000
Goodwill and Intangibles	65,200,000,000	61,386,000,000	60,690,000,000	58,674,000,000
Total Assets	110,343,000,000	97,321,000,000	98,726,000,000	97,154,000,000
Liabilities
Account Payables	0	3,079,000,000	2,872,000,000	3,381,000,000
Short Term Debt	3,533,000,000	2,475,000,000	3,604,000,000	5,851,000,000
Total Current Liabilities	15,189,000,000	13,332,000,000	14,012,000,000	17,010,000,000
Long Term Debt	35,852,000,000	30,300,000,000	31,308,000,000	28,909,000,000
Total Liabilities	56,807,000,000	47,650,000,000	51,884,000,000	53,006,000,000
Shareholders Equity
Retained Earnings	0	53,102,000,000	47,364,000,000	41,910,000,000
Total Shareholders Equity	53,415,000,000	49,584,000,000	46,735,000,000	43,978,000,000

Cash flow quarterly history for Thermo Fisher Scientific Inc (0R0H.L).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	6,721,000,000	6,338,000,000	5,995,000,000	6,950,000,000
Depreciation & Amortization	2,780,000,000	3,108,000,000	3,406,000,000	3,381,000,000
Stock Based Compensation	0	301,000,000	278,000,000	307,000,000
Change in Working Capital	-1,808,000,000	-334,000,000	-537,000,000	-1,049,000,000
Operating Cash Flow	7,818,000,000	8,667,000,000	8,406,000,000	9,154,000,000
Investing Activities
Capital Expenditure	-1,525,000,000	-1,400,000,000	-1,479,000,000	-2,243,000,000
Investments	-1,525,000,000	-1,400,000,000	-1,479,000,000	-2,243,000,000
Investing Cash Flow	-4,047,000,000	-5,841,000,000	-5,142,000,000	-2,159,000,000
Financing Activities
Debt Repayment	5,347,000,000	-2,403,000,000	-155,000,000	-654,000,000
Common Stock Issued/Repurchased	-3,000,000,000	-4,000,000,000	-3,000,000,000	375,000,000
Dividends Paid	-636,000,000	-583,000,000	-523,000,000	-455,000,000
Financing Cash Flow	1,801,000,000	-6,792,000,000	-3,622,000,000	-2,810,000,000
Summary
Free Cash Flow	6,293,000,000	7,267,000,000	6,927,000,000	6,911,000,000
Net Change in Cash	5,839,000,000	-4,057,000,000	-440,000,000	4,046,000,000

Cash flow annual history for Thermo Fisher Scientific Inc (0R0H.L).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	6,721,000,000	6,338,000,000	5,995,000,000	6,950,000,000
Depreciation & Amortization	2,780,000,000	3,108,000,000	3,406,000,000	3,381,000,000
Stock Based Compensation	0	301,000,000	278,000,000	307,000,000
Change in Working Capital	-1,808,000,000	-334,000,000	-537,000,000	-1,049,000,000
Operating Cash Flow	7,818,000,000	8,667,000,000	8,406,000,000	9,154,000,000
Investing Activities
Capital Expenditure	-1,525,000,000	-1,400,000,000	-1,479,000,000	-2,243,000,000
Investments	-1,525,000,000	-1,400,000,000	-1,479,000,000	-2,243,000,000
Investing Cash Flow	-4,047,000,000	-5,841,000,000	-5,142,000,000	-2,159,000,000
Financing Activities
Debt Repayment	5,347,000,000	-2,403,000,000	-155,000,000	-654,000,000
Common Stock Issued/Repurchased	-3,000,000,000	-4,000,000,000	-3,000,000,000	375,000,000
Dividends Paid	-636,000,000	-583,000,000	-523,000,000	-455,000,000
Financing Cash Flow	1,801,000,000	-6,792,000,000	-3,622,000,000	-2,810,000,000
Summary
Free Cash Flow	6,293,000,000	7,267,000,000	6,927,000,000	6,911,000,000
Net Change in Cash	5,839,000,000	-4,057,000,000	-440,000,000	4,046,000,000